Literature DB >> 17465989

Genome wide copy number abnormalities in pediatric medulloblastomas as assessed by array comparative genome hybridization.

Ken C Lo1, Michael R Rossi, Charles G Eberhart, John K Cowell.   

Abstract

Array-based comparative genomic hybridization was used to characterize 22 medulloblastomas in order to precisely define genetic alterations in these malignant childhood brain tumors. The 17p(-)/17q(+) copy number abnormality (CNA), consistent with the formation of isochromosome 17q, was the most common event (8/22). Amplifications in this series included MYCL, MYCN and MYC previously implicated in medulloblastoma pathogenesis, as well as novel amplicons on chromosomes 2, 4, 11 and 12. Losses involving chromosomes 1, 2, 8, 10, 11, 16 and 19 and gains of chromosomes 4, 7, 8, 9 and 18 were seen in greater than 20% of tumors in this series. A homozygous deletion in 11p15 defines the minimal region of loss on this chromosome arm. In order to map the minimal regions involved in losses, gains and amplifications, we combined aCGH data from this series with that of two others obtained using the same RPCI BAC arrays. As a result of this combined analysis of 72 samples, we have defined specific regions on chromosomes 1, 8p, 10q, 11p and 16q which are frequently involved in CNAs in medulloblastomas. Using high density oligonucleotide expression arrays, candidate genes were identified within these consistently involved regions in a subset of the tumors.

Entities:  

Mesh:

Year:  2007        PMID: 17465989     DOI: 10.1111/j.1750-3639.2007.00072.x

Source DB:  PubMed          Journal:  Brain Pathol        ISSN: 1015-6305            Impact factor:   6.508


  10 in total

1.  Integrative genomic analysis of medulloblastoma identifies a molecular subgroup that drives poor clinical outcome.

Authors:  Yoon-Jae Cho; Aviad Tsherniak; Pablo Tamayo; Sandro Santagata; Azra Ligon; Heidi Greulich; Rameen Berhoukim; Vladimir Amani; Liliana Goumnerova; Charles G Eberhart; Ching C Lau; James M Olson; Richard J Gilbertson; Amar Gajjar; Olivier Delattre; Marcel Kool; Keith Ligon; Matthew Meyerson; Jill P Mesirov; Scott L Pomeroy
Journal:  J Clin Oncol       Date:  2010-11-22       Impact factor: 44.544

2.  An interferon response gene expression signature is activated in a subset of medulloblastomas.

Authors:  Eike Staub
Journal:  Transl Oncol       Date:  2012-08-01       Impact factor: 4.243

3.  Genome-wide molecular characterization of central nervous system primitive neuroectodermal tumor and pineoblastoma.

Authors:  Suzanne Miller; Hazel A Rogers; Paul Lyon; Vikki Rand; Martyna Adamowicz-Brice; Steven C Clifford; James T Hayden; Sara Dyer; Stefan Pfister; Andrey Korshunov; Marie-Anne Brundler; James Lowe; Beth Coyle; Richard G Grundy
Journal:  Neuro Oncol       Date:  2011-08       Impact factor: 12.300

4.  Novel amplifications in pediatric medulloblastoma identified by genome-wide copy number profiling.

Authors:  Helena Nord; Susan Pfeifer; Pelle Nilsson; Johanna Sandgren; Svetlana Popova; Bo Strömberg; Irina Alafuzoff; Monica Nistér; Teresita Díaz de Ståhl
Journal:  J Neurooncol       Date:  2011-10-07       Impact factor: 4.130

Review 5.  Biological background of pediatric medulloblastoma and ependymoma: a review from a translational research perspective.

Authors:  Judith M de Bont; Roger J Packer; Erna M Michiels; Monique L den Boer; Rob Pieters
Journal:  Neuro Oncol       Date:  2008-08-01       Impact factor: 12.300

6.  Pediatric primary intramedullary spinal cord glioblastoma.

Authors:  Robert Lober; Suash Sharma; Beverly Bell; Alan Free; Ramon Figueroa; Chris W Sheils; Mark Lee; John Cowell
Journal:  Rare Tumors       Date:  2010-09-30

7.  Initial testing (stage 1) of the curaxin CBL0137 by the pediatric preclinical testing program.

Authors:  Richard Lock; Hernan Carol; John M Maris; E Anders Kolb; Richard Gorlick; C Patrick Reynolds; Min H Kang; Stephen T Keir; Jianrong Wu; Andrei Purmal; Andrei Gudkov; Dias Kurmashev; Raushan T Kurmasheva; Peter J Houghton; Malcolm A Smith
Journal:  Pediatr Blood Cancer       Date:  2016-09-21       Impact factor: 3.167

8.  Genetic fingerprinting of the development and progression of T-cell lymphoma in a murine model of atypical myeloproliferative disorder initiated by the ZNF198-fibroblast growth factor receptor-1 chimeric tyrosine kinase.

Authors:  Mingqiang Ren; Xiurong Li; John K Cowell
Journal:  Blood       Date:  2009-06-08       Impact factor: 22.113

Review 9.  Treatment of pediatric brain tumors.

Authors:  Matthias Karajannis; Jeffrey C Allen; Elizabeth W Newcomb
Journal:  J Cell Physiol       Date:  2008-12       Impact factor: 6.384

10.  Recurrent genomic alterations characterize medulloblastoma arising from DNA double-strand break repair deficiency.

Authors:  Pierre-Olivier Frappart; Youngsoo Lee; Helen R Russell; Nader Chalhoub; Yong-Dong Wang; Kenji E Orii; Jingfeng Zhao; Naomi Kondo; Suzanne J Baker; Peter J McKinnon
Journal:  Proc Natl Acad Sci U S A       Date:  2009-01-21       Impact factor: 11.205

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.